Aridis Pharmaceuticals, Inc. (ARDS) Financials

ARDS Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2023 6.5 million 18.3 million
June 30, 2023 6.5 million 21.4 million
March 31, 2023 9.4 million 37.3 million
Dec. 31, 2022 14.7 million 38.9 million

ARDS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2023 -983000 200000
June 30, 2023 -4.3 million 210000
March 31, 2023 -4.0 million 245000
Dec. 31, 2022 -8.6 million 318000

ARDS Net Income

No data available :(

ARDS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2023 35000 854000 1.4 million
June 30, 2023 19000 1.0 million 1.6 million
March 31, 2023 1.3 million 1.1 million 1.7 million
Dec. 31, 2022 4.9 million 1.3 million 1.8 million

ARDS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2023 37.4 million
June 30, 2023 36.6 million
March 31, 2023 22.0 million
Dec. 31, 2022 27.0 million

ARDS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2023 - 175000 1.1 million -
June 30, 2023 - 4.7 million 1.3 million -
March 31, 2023 49000 5.5 million 1.8 million -
Dec. 31, 2022 49000 7.0 million 1.6 million -

ARDS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2023 417000 -
June 30, 2023 19.6 million -
March 31, 2023 - -
Dec. 31, 2022 - -

ARDS Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ARDS

Price: $0

52 week price:
0.00
0.05

Earnings Per Share: -0.02 USD

P/E Ratio: -0.01

Exchange: OEM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 543871

Market Capitalization: 4457

Links: